Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2016

Feb 1, 2016

34519_dirs_2016-02-01_6e49aa75-8867-4ad9-a4c7-73522c117062.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2016-01-29

Reporting Person: Tomsche David Scott (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-01-29 Common Stock, par value $0.10 per share P 6666.0000 $5.2500 Acquired 65834.0000 Direct

Footnotes

F1: This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.